Published on Web 04/09/2008
Syntheses of the Stemona Alkaloids (()-Stenine,
(()-Neostenine, and (()-13-Epineostenine Using a
Stereodivergent Diels–Alder/Azido-Schmidt Reaction
Kevin J. Frankowski, Jennifer E. Golden, Yibin Zeng, Yao Lei, and Jeffrey Aubé*
Department of Medicinal Chemistry and Center for Chemical Methodologies and Library
DeVelopment, UniVersity of Kansas, Malott Hall, Room 4070, 1251 Wescoe Hall DriVe,
Lawrence, Kansas 66045-7582
Received January 29, 2008; E-mail: jaube@ku.edu
Abstract: A tandem Diels–Alder/azido-Schmidt reaction sequence provides rapid access to the core skeleton
shared by several Stemona alkaloids including stenine, neostenine, tuberostemonine, and neotuberostemonine.
The discovery and evolution of inter- and intramolecular variations of this process and their applications to
total syntheses of (()-stenine and (()-neostenine are described. The stereochemical outcome of the reaction
depends on both substrate type and reaction conditions, enabling the preparation of both (()-stenine and
(()-neostenine from the same diene/dienophile combination.
Chinese and Japanese traditional medicines have for centuries
utilized extracts of stemonaceous plants as remedies for the
treatment of respiratory ailments. These extracts and the isolated
Stemona alkaloids have been associated with insecticidal,
anthelmintic, antitussive, and various neurochemical effects,
although mechanisms have rarely been identified.1 Recently,
interest in these alkaloids was further piqued by the demonstra-
tion of effective in vivo activity of two skeletally related
Stemona alkaloids, neostenine 3 and neotuberostemonine 4,
against citric acid induced cough in guinea pig animal models.2
In addition, the Stemona alkaloid tuberostemonine 2 has
demonstrated inhibitory activity on excitatory transmission at
the crayfish neuromuscular junction.3 The Stemona alkaloids
have attracted substantial interest from synthetic chemists partly
because of these links to biological activity and partly from their
challenging structural complexity. Stenine has been the focus
of several successful synthetic efforts4 and has inspired a number
of synthetic approaches.5 In addition, tuberostemonine 2 was
synthesized by Wipf.6 However the stenine isomer, neostenine
3, had not yet been prepared via total synthesis at the outset of
this project7(Figure 1).
A noteworthy challenge in any stenine synthesis is the
construction of the B ring, which is fused to three additional
rings. In addition, each of its carbon atoms is a stereogenic
center. This issue was addressed using an intramolecular
Diels–Alder cyclization in three out of the four first-published
syntheses of this target (Scheme 1; the stenine numbering system
used throughout is that presented in a recent review1f). The first
synthesis of stenine by Hart in 1990 not only set the precedent
for utilizing a Diels–Alder approach to this target but also
established an iodolactonization/Keck allylation sequence as a
solutiontotheproblemofstereoselectiveethylgroupinstallation.4a,b
Morimoto utilized a chiral oxazoline-based intramolecular
Diels–Alder cyclization of 5 to synthesize the naturally occurring
enantiomer of stenine.4c–e Padwa applied an impressive Diels–
Alder/ring opening/1,2-methylthioshift cascade to append the
B and D rings onto an existing seven-membered C ring in a
single operation.4g,h Of all the completed syntheses to date, only
the route used by Wipf does not employ a Diels–Alder approach
for the construction of the cyclohexane ring.4f These workers
utilized the selective reduction of a π-allyl palladium complex
(1) (a) For reviews, see: Götz, M.; Edwards, O. E. In The Alkaloids;
Manske, R. H. F., Ed.; Academic Press: New York, 1967; Vol 9, pp
545–551. (b) Götz, M.; Strunz, G. M. In Alkaloids; Wiesner, K., Ed.;
Butterworth: London, 1973; Vol. 9, pp 143–160. (c) Lin, W.-H.; Ye,
Y.; Xu, R.-S. J. Nat. Prod. 1992, 55, 571–576. (d) Xu, R.-S. Stud.
Nat. Prod. Chem. 2000, 21, 729–772. (e) Pilli, R. A.; Ferreira de
Oliveira, M. d. C Nat. Prod. Rep. 2000, 17, 117–127. (f) Greger, H.
Planta Med. 2006, 72, 99–113. (g) Xu, Y.-T.; Hon, P.-M.; Jiang, R.-
W.; Cheng, L.; Li, S.-H.; Chan, Y.-P.; Xu, H.-X.; Shaw, P.-C.; But,
P. P.-H. J. Ethnopharmacol. 2006, 108, 46–53.
(2) (a) Chung, H.-S.; Hon, P.-M.; Lin, G.; But, P. P-H.; Dong, H. Planta
Med. 2003, 69, 914–920. (b) Leung, P. H. H.; Zhang, L.; Zuo, Z.;
Lin, G Planta Med. 2006, 72, 211–216.
(5) (a) Morimoto, Y.; Nishida, K.; Hayashi, Y.; Shirahama, H. Tetrahedron
Lett. 1993, 34, 5773–5776. (b) Morimoto, Y.; Iwahashi, M. Synlett
1995, 1221–1222. (c) Goldstein, D. M.; Wipf, P. Tetrahedron Lett.
1996, 37, 739–42. (d) Jung, S. H.; Lee, J. E.; Joo, H. J.; Kim, S. H.;
Koh, H. Y. Bull. Korean Chem. Soc. 2000, 21, 159–160. (e) Booker-
Milburn, K. I.; Hirst, P.; Charmant, J. P. H.; Taylor, L. H. J. Angew.
Chem., Int. Ed. 2003, 42, 1642–1644. (f) Zhu, L.; Lauchli, R.; Loo,
M.; Shea, K. J. Org. Lett. 2007, 9, 2269–2271.
(3) Shinozaki, H.; Ishida, M. Brain Res. 1985, 334, 33–40.
(4) (a) Chen, C.-Y.; Hart, D. J. Org. Chem. 1990, 55, 6236–6240. (b)
Chen, C.-Y.; Hart, D. J. Org. Chem. 1993, 58, 3840–3849. (c)
Morimoto, Y.; Iwahashi, M.; Nishida, K.; Hayashi, Y.; Shirahama,
H. Angew. Chem. 1996, 108, 968–970. (d) Morimoto, Y.; Iwahashi,
M.; Nishida, K.; Hayashi, Y.; Shirahama, H. Angew. Chem., Int. Ed.
Engl. 1996, 35, 904–906. (e) Morimoto, Y.; Iwahashi, M.; Kinoshita,
T.; Nishida, K. Chem.sEur. J. 2001, 7, 4107–4116. (f) Wipf, P.; Kim,
Y.; Goldstein, D. M. J. Am. Chem. Soc. 1995, 117, 11106–11112. (g)
Ginn, J. D.; Padwa, A. Org. Lett. 2002, 4, 1515–1517. (h) Padwa, A.;
Ginn, J. D. J. Org. Chem. 2005, 70, 5197–5206.
(6) (a) Wipf, P.; Spencer, S. R.; Takahashi, H J. Am. Chem. Soc. 2002,
124, 14848–14849. (b) Wipf, P.; Spencer, S. R. J. Am. Chem. Soc.
2005, 127, 225–235.
(7) Professor Kevin Booker-Milburn and coworkers have recently com-
pleted an independent synthesis of neostenine (personal communica-
tion).
9
6018 J. AM. CHEM. SOC. 2008, 130, 6018–6024
10.1021/ja800574m CCC: $40.75
2008 American Chemical Society